The Renal Biomarkers Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Renal Biomarkers Market:
https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report

According to The Business Research Company’s Renal Biomarkers Global Market Report 2024, The renal biomarkers market size has grown strongly in recent years. It will grow from $1.17 billion in 2023 to $1.27 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing prevalence of kidney diseases, advances in medical diagnostics, aging population, growing awareness of early disease detection, adoption of point-of-care testing, rise in chronic diseases..

The renal biomarkers market size is expected to see strong growth in the next few years. It will grow to $1.74 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to personalized medicine and targeted therapies, integration of biomarker testing into routine clinical practice, emerging markets in asia and latin america, non-invasive biomarker testing methods, continuous monitoring with wearable devices.. Major trends in the forecast period include multiplex biomarker panels for comprehensive disease profiling, ai and machine learning for biomarker discovery, biomarker-based companion diagnostics, poc biomarker testing in home healthcare settings, biomarkers for early detection and prevention..

The rise in geriatric and paediatric renal patients is expected to propel the growth of the renal biomarkers market going forward. Geriatric renal patients refer to the elderly patients aged above 70 years with advanced chronic kidney disease (CKD). However, paediatric renal patients refer to the patients who are commonly diagnosed with renal disorder during childhood and young adulthood. Renal biomarkers help to evaluate the severity of renal injury in geriatric and paediatric renal patients. For instance, in March 2021, according to the data published by the Centers for Disease Control and Prevention, a US-based government administrative agency, nearly 37 million adults in the US have chronic renal disease and it is more prevalent in adults 65 years of age and older (38%). Therefore, the rise in geriatric and paediatric renal patients is driving the growth of the renal biomarkers market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=7711&type=smp

The renal biomarkers market covered in this report is segmented –
1) Renal Biomarkers Market By Biomarker Type: Functional Biomarker, Up Regulated Protein, Other Biomarker Types
2) Renal Biomarkers Market By Diagnostic Technique: Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LS-MS)
3) Renal Biomarkers Market By Application: Diagnosis And Disease Progression Monitoring, Research Homecare
4) Renal Biomarkers Market By End User: Hospitals, Diagnostic Laboratories, Other End Users

Technological advancements have emerged as a key trend gaining popularity in the renal biomarkers market. Major players operating in the renal biomarkers sector is focused on developing innovative technologies to sustain their position in the market. For instance, In January 2021, RenalytixAI, a UK-based developer of artificial intelligence (AI) enabled clinical diagnostic solutions for kidney disease, partnered with DaVita to develop KidneyIntelX. KidneyIntelX is a diagnostic tool powered by artificial intelligence to help spot those at risk of renal disease or kidney failure. KidneyIntelX uses a machine-learning algorithm to produce a patient-specific risk assessment based on blood biomarkers and electronic medical information.

The renal biomarkers market report table of contents includes:

1. Executive Summary

2. Renal Biomarkers Market Characteristics

3. Renal Biomarkers Market Trends And Strategies

4. Renal Biomarkers Market - Macro Economic Scenario

5. Global Renal Biomarkers Market Size and Growth

.......

31. Global Renal Biomarkers Market Competitive Benchmarking

32. Global Renal Biomarkers Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Renal Biomarkers Market

34. Renal Biomarkers Market Future Outlook and Potential Analysis

35. Appendix

Read Related Reports:

https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report

Contact Us:

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model